News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Janssen Pharmaceutical K.K. and Taiwan University Team Up to Fight Hepatitis B


6/5/2013 9:06:40 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 4, 2013 -- Janssen Pharma and the National Taiwan University Hospital will co-develop new drugs for hepatitis B. Janssen, the drug development subsidiary of Johnson & Johnson, will supply drug candidates to Pei-jer Chen, MD, a noted hepatitis B researcher at NTU College of Medicine. Dr. Chen will test how patients and the disease react to the compounds. The company expects to spend $7 million on the project in its first three years. More details....

Stock Symbol: (NYSE: JNJ)



Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES